Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Energy Specific Far Infrared Radiation Treatment for Sciatica

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by GAAD Medical Research Institute Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
GAAD Medical Research Institute Inc.
ClinicalTrials.gov Identifier:
NCT00573807
First received: December 12, 2007
Last updated: January 2, 2009
Last verified: January 2009

December 12, 2007
January 2, 2009
January 2006
March 2008   (final data collection date for primary outcome measure)
The primary end point is to determine the therapeutic effects of far infrared radiation on the Sciatic nerve. [ Time Frame: 2 years and 6 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00573807 on ClinicalTrials.gov Archive Site
Far infrared treatment for other pain syndromes [ Time Frame: 2 years and 6 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Energy Specific Far Infrared Radiation Treatment for Sciatica
Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Sciatica.

A preliminary study to determine the use of far infrared radiation for the treatment of back pain

Sciatica is created by joint misalignment, muscle spasm and inflammation. Generally, sciatica is a combination of lower back pain, pain radiating into the buttock and possibly down the leg.

Far infrared radiation of the sciatic nerve, coupled with the stretching of the spinal cord, is a promising non-invasive method for treating sciatica.

Interventional
Phase 1
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Sciatica
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Far Infrared Radiation (5μm to 20μm wavelength)for 30 to 40 minutes per treatment session.
1
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
2
December 2008
March 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Persons with lower back pain

Exclusion Criteria:

  • None
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00573807
GAAD-SCIA-CTP1
Yes
Dr. Kwasi Donyina/Founder & President, GAAD Medical Research Institute Inc.
GAAD Medical Research Institute Inc.
Not Provided
Study Director: Ken Nedd, M.D. GAAD Medical Research Institute Inc.
Study Chair: Kwasi Donyina, Ph.D. GAAD Medical Research Institute Inc.
GAAD Medical Research Institute Inc.
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP